
1025 women who had used Depo-Provera 150 mg injections for contraception for 3-8 1/2 years were studied to assess the effects of prolonged use. 24.4% were aged 25-29, 33.7% were 30-34, 25.1% were 35-39, 11.2% were 40-44, and the rest were 24 and under. 47.2% had had 5-8 pregnancies and 36.3% had had 9 or more. 78.3% had had at least 5 births. 93.4% had menstrual cycles averaging 26-32 days before treatment. 74% had used no previous contraception, 18.9% used oral contraceptives (OCs), .9% used a monthly injectable, 2.9% used another trimonthly injectable, 3.1% used IUD, and .1% each used condoms and rhythm. 58.6% had amenorrhea while using Depo-Provera and 73.5% of the others had short bleeding episodes of 1-2 days. 62% of 92 endometrial biopsies indicated varying degrees of endometrial atrophy. 5 cases of benign breast adenomas were confirmed by biopsy. 71 women complained of moderate breast tenderness. No cases of breast cancer were observed. 73% gained and 9.2% lost at least 1 kg in weight. No significant changes in blood pressure were noted. The proportion of women reporting inorgasmic sexual response increased from 50.3% at the beginning of use to 75.3% after 12-38 doses of Depo-Provera. 3 pregnancies occurred, 2 possibly resulting from faulty injection technique. A follow-up study of 80 former users for 1 year showed that 39 of 58 cases of amenorrhea resumed menses in an average time of 8-9 months, and 19 did not resume menstruation. 10 of 48 with weight changes did not return to the former weight. Nervousness, amenorrhea, and acne were the symptoms requiring the longest time to disappear. 29 of 46 women complaining of frigidity and 2 of 15 complaining of dyspareunia failed to improve. 11.2% of the 80 women terminated use to achieve pregnancy. Other factors were amenorrhea (72.5%), weight gain (60%), edema (50%), nervousness (45%), sexual problems (81.2%), and hypertension (3.7%).
Family planning programs were implemented in Mexico in 1973; since then the number of family planning acceptors has grown considerably; however, the number of illegal abortions has also been on the increase. Such phenomenon has been noticed in other countries under the same circumstances, notably Korea, India, and Chile. Women in large urban areas tend to abandon family planning programs for lack of specific information and of adequate and specialized attention. In 1977 in the state of Puebla 32.6% of the total number of pregnancies were terminated in abortion, often induced with primitive and unsanitary methods. It is essential to educate young and very young people on the idea of responsible paternity, and to offer them adequate sex education in schools and outside schools. The general physician can play a very important role in advising these people and in spreading the principle of family planning.
Selection of vasectomy patients must be done very conscientiously; only emotionally mature people should be selected, with stable marriages, and 2-3 children over 6. Written authorization from both spouses is indispensable, at least in Mexico. Operative procedures are simple and safe, and can be performed under local anesthesia; a 1-day rest is advisable. Complications include infection, epididymitis and granuloma; such occurrences, however, are extremely rare and easily treatable.